Clinical Trial Update: The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether urea cream reduces hand-foot skin reaction caused by sorafenib in hepatocellular carcinoma patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Urea cream (urea cream)

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED